Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Alaunos Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -1.0 M, a 7.33% decrease year-over-year.
• Alaunos Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -4.3 M, a 65.96% decrease year-over-year.
• Alaunos Therapeutics Inc. annual operating income for 2025 was -4.2 M, a 12.20% decrease from 2024.
• Alaunos Therapeutics Inc. annual operating income for 2024 was -4.8 M, a 85.96% decrease from 2023.
• Alaunos Therapeutics Inc. annual operating income for 2023 was -34.3 M, a 2.39% decrease from 2022.
• Alaunos Therapeutics Inc. annual operating income for 2022 was -35.1 M.